Statin-Associated Muscle Symptoms (SAMS) Explained
Statin-associated muscle symptoms (SAMS) are muscle-related side effects that can occur during statin therapy, ranging from mild muscle pain to rare severe muscle damage.
Things worth knowing about "Statin-associated muscle symptoms"
Statin-associated muscle symptoms (SAMS) are muscle-related side effects that can occur during statin therapy, ranging from mild muscle pain to rare severe muscle damage.
What are statin-associated muscle symptoms?
Statin-associated muscle symptoms (SAMS) refer to a spectrum of muscle-related complaints that can develop during treatment with statins – cholesterol-lowering medications that are among the most widely prescribed drugs worldwide. While statins are generally well tolerated and provide significant cardiovascular benefits, a subset of patients experiences muscle-related side effects that can range from mild discomfort to rare but serious muscle damage.
Types and severity
SAMS are classified into several categories based on their severity:
- Myalgia: Muscle pain or weakness without elevated muscle enzyme levels in the blood. This is the most common form.
- Myositis: Muscle inflammation accompanied by elevated creatine kinase (CK) levels in the blood.
- Myopathy: A general term for muscle disease, with or without elevated CK levels.
- Rhabdomyolysis: A severe and rare form involving extensive muscle breakdown, markedly elevated CK levels, and the risk of acute kidney failure. This is a medical emergency.
Causes and risk factors
The exact mechanisms behind SAMS are not yet fully understood. Current hypotheses include:
- Inhibition of coenzyme Q10 synthesis, which may impair energy production in muscle cells
- Disruption of calcium homeostasis in muscle tissue
- Genetic variants, particularly in the SLCO1B1 gene, which regulates statin transport into liver cells
- Mitochondrial dysfunction
Several factors are known to increase the risk of SAMS:
- Older age
- Female sex
- Kidney or liver disease
- Hypothyroidism (underactive thyroid)
- Concurrent use of interacting medications (e.g., fibrates, certain antibiotics, immunosuppressants)
- High statin doses
- Intense physical exercise
Symptoms
Typical symptoms of SAMS include:
- Muscle pain (myalgia), most commonly in large muscle groups such as the thighs, buttocks, and shoulders
- Muscle weakness, often noticed during daily activities such as climbing stairs
- Muscle cramps
- A general feeling of fatigue or heaviness in the muscles
- In cases of rhabdomyolysis: dark (brown or cola-colored) urine, general malaise, and fever
Symptoms typically appear within weeks to months after starting statin therapy or following a dose increase.
Diagnosis
The diagnosis of SAMS is based on clinical assessment and laboratory testing:
- Measurement of creatine kinase (CK) in the blood as a marker of muscle damage
- Thyroid function tests (TSH) to rule out hypothyroidism
- Kidney and liver function tests
- Exclusion of other causes of muscle symptoms (e.g., inflammatory muscle diseases)
- A statin discontinuation trial: if symptoms improve within 2–4 weeks of stopping the statin, a causal relationship is likely
The SAMS Clinical Index is a validated tool used to assess the probability of a causal link between statin use and muscle complaints.
Treatment and management
Management of SAMS depends on the severity of symptoms:
Mild to moderate symptoms
- Temporary discontinuation of the statin to assess symptom resolution
- Switching to a different statin (e.g., from simvastatin to rosuvastatin or pravastatin, which are generally better tolerated)
- Dose reduction
- Switching to an intermittent dosing schedule (e.g., three times per week)
Alternative treatment options
- Ezetimibe: A non-statin cholesterol-lowering agent that can be used as an alternative or add-on therapy
- PCSK9 inhibitors: Biologic agents for cholesterol reduction in patients who cannot tolerate statins
- Bempedoic acid: A novel cholesterol-lowering drug with a different mechanism of action
Severe cases (rhabdomyolysis)
- Immediate discontinuation of the statin
- Hospitalization with aggressive intravenous fluid therapy to protect kidney function
- Close monitoring of renal function
Important: Patients should never stop taking a statin without consulting their healthcare provider, as statins play a critical role in preventing heart attacks and strokes.
Prevention
To reduce the risk of SAMS, the following measures are recommended:
- Regular monitoring of CK levels, especially at the start of therapy
- Using the lowest effective statin dose
- Reviewing potential drug interactions
- Considering individual patient risk factors before initiating therapy
References
- Stroes E.S. et al. - Statin-associated muscle symptoms: impact on statin therapy - European Heart Journal (2015), European Atherosclerosis Society Consensus Panel Statement.
- Grundy S.M. et al. - 2018 AHA/ACC Guideline on the Management of Blood Cholesterol - Journal of the American College of Cardiology (2019).
- Laufs U. et al. - Clinical Review on Muscle Side Effects of Statins - Circulation (2015).
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.